To include your compound in the COVID-19 Resource Center, submit it here.

Endocrine / Metabolic

INDICATION: Diabetes

Patient sample and mouse studies suggest inhibiting miR-181a or NFAT5 could help treat

Read the full 146 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE